Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1958 1
1959 1
1960 2
1961 2
1963 4
1964 1
1966 1
1968 4
1969 3
1972 1
1974 1
1975 1
1976 2
1978 1
1979 4
1980 4
1981 1
1982 2
1983 3
1984 2
1985 4
1986 3
1987 2
1988 5
1989 4
1990 3
1991 2
1992 3
1993 6
1994 7
1995 7
1996 14
1997 11
1998 20
1999 17
2000 8
2001 16
2002 16
2003 24
2004 18
2005 13
2006 23
2007 22
2008 26
2009 21
2010 22
2011 36
2012 41
2013 39
2014 33
2015 34
2016 29
2017 33
2018 56
2019 53
2020 62
2021 84
2022 87
2023 91
2024 86
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,014 results

Results by year

Filters applied: . Clear all
Page 1
Current Overview of Treatment for Metastatic Bone Disease.
Tsukamoto S, Kido A, Tanaka Y, Facchini G, Peta G, Rossi G, Mavrogenis AF. Tsukamoto S, et al. Curr Oncol. 2021 Aug 29;28(5):3347-3372. doi: 10.3390/curroncol28050290. Curr Oncol. 2021. PMID: 34590591 Free PMC article. Review.
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.
Nakazawa Y, Miyano M, Tsukamoto S, Kogai H, Yamamoto A, Iso K, Inoue S, Yamane Y, Yabe Y, Umihara H, Taguchi J, Akagi T, Yamaguchi A, Koga M, Toshimitsu K, Hirayama T, Mukai Y, Machinaga A. Nakazawa Y, et al. Among authors: tsukamoto s. Nat Commun. 2024 Mar 11;15(1):2192. doi: 10.1038/s41467-024-46167-1. Nat Commun. 2024. PMID: 38467634 Free PMC article.
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression.
Matsui S, Ri C, Bolanos LC, Choi K, Shibamiya A, Ishii A, Takaishi K, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Mimura N, Yoshimi A, Yokote K, Starczynowski DT, Sakaida E, Muto T. Matsui S, et al. Among authors: tsukamoto s. Leukemia. 2024 May;38(5):1032-1045. doi: 10.1038/s41375-024-02245-3. Epub 2024 Apr 12. Leukemia. 2024. PMID: 38609495 Free PMC article.
Foreword.
Tsukamoto S. Tsukamoto S. Chem Pharm Bull (Tokyo). 2016;64(2):95. doi: 10.1248/cpb.c16-ctf6402. Chem Pharm Bull (Tokyo). 2016. PMID: 26833436 Free article. No abstract available.
Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).
Takashima A, Hamaguchi T, Mizusawa J, Nagashima F, Ando M, Ojima H, Denda T, Watanabe J, Shinozaki K, Baba H, Asayama M, Hasegawa S, Masuishi T, Nakata K, Tsukamoto S, Katayama H, Nakamura K, Fukuda H, Kanemitsu Y, Shimada Y; Colorectal Cancer Study Group in Japan Clinical Oncology Group (JCOG). Takashima A, et al. Among authors: tsukamoto s. J Clin Oncol. 2024 Nov 20;42(33):3967-3976. doi: 10.1200/JCO.23.02722. Epub 2024 Aug 26. J Clin Oncol. 2024. PMID: 39186709 Clinical Trial.
How Does Omitting Additional Surgery After Local Excision Affect the Prognostic Outcome of Patients With High-risk T1 Colorectal Cancer?
Ouchi A, Komori K, Masahiro T, Toriyama K, Kajiwara Y, Oka S, Fukunaga Y, Hotta K, Ikematsu H, Tsukamoto S, Nagata S, Yamada K, Konno M, Ishihara S, Saitoh Y, Matsuda K, Togashi K, Ishiguro M, Kuwai T, Okuyama T, Ohuchi A, Ohnuma S, Sakamoto K, Sugai T, Katsumata K, Matsushita HO, Nakai K, Uraoka T, Akimoto N, Kobayashi H, Ajioka Y, Sugihara K, Ueno H; Study Group for the JSCCR-T study. Ouchi A, et al. Among authors: tsukamoto s. Ann Surg. 2024 Feb 1;279(2):290-296. doi: 10.1097/SLA.0000000000006092. Epub 2023 Sep 5. Ann Surg. 2024. PMID: 37669045
Effect of preceding drug therapy on the renal and cardiovascular outcomes of combined sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes and chronic kidney disease.
RECAP study group; Tsukamoto S, Kobayashi K, Toyoda M, Tone A, Kawanami D, Suzuki D, Tsuriya D, Machimura H, Shimura H, Wakui H, Takeda H, Yokomizo H, Takeshita K, Chin K, Kanasaki K, Miyauchi M, Saburi M, Morita M, Yomota M, Kimura M, Hatori N, Nakajima S, Ito S, Murata T, Matsushita T, Furuki T, Hashimoto T, Umezono T, Muta Y, Takashi Y, Tamura K. RECAP study group, et al. Among authors: tsukamoto s. Diabetes Obes Metab. 2024 Aug;26(8):3248-3260. doi: 10.1111/dom.15652. Epub 2024 May 19. Diabetes Obes Metab. 2024. PMID: 38764356
Periostin in Cancer-Associated Fibroblasts Promotes Esophageal Squamous Cell Carcinoma Progression by Enhancing Cancer and Stromal Cell Migration.
Miyako S, Koma YI, Nakanishi T, Tsukamoto S, Yamanaka K, Ishihara N, Azumi Y, Urakami S, Shimizu M, Kodama T, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H. Miyako S, et al. Among authors: tsukamoto s. Am J Pathol. 2024 May;194(5):828-848. doi: 10.1016/j.ajpath.2023.12.010. Epub 2024 Feb 5. Am J Pathol. 2024. PMID: 38320632 Free article.
1,014 results